
GSK, Spero Stop UTI Drug Trial After Early Success
(Reuters) -Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract infections early as the study met its main goal, the companies said on Wednesday. Shares of Spero more than tripled to …